Search clinical trials for: Glimepiride→Evogliptin→Evogliptin Glimepiride

Total 323 results

Dong-A ST Co., Ltd.

Completed

Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5mg and Glimepiride 4mg

Type2 Diabetes

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5 mg and Pioglitazone 30 mg

Type 2 Diabetes

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Pharmacokinetic and Pharmacodynamic Drug-Drug Interaction of Evogliptin and Empagliflozin or Dapagliflozin in Healthy Male Adults

Type2 Diabetes

Korea, Republic of
Takeda

Completed

Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in Japan

Type 2 Diabetes Mellitus
Takeda

Completed

Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in Japan

Type 2 Diabetes Mellitus
Dong-A ST Co., Ltd.

Completed

PK//PD/Tolerability Study of DA-1229(Evogliptin) in Renal Impaired Patients

Renal Impairment

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

The Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of Evogliptin in Hemodialysis Patients

Hemodialysis Patients

Korea, Republic of
DongGuk University

Unknown

Effect of Evogliptin on Bone Metabolism in Human

Diabetes Mellitus, Type 2 | Osteoporosis

Korea, Republic of
REDNVIA Co., Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)

Calcific Aortic Valve Disease

United States
Seoul National University Hospital

Unknown

Glimepiride, Alogliptin and Alogliptin+Pioglitazone Combination

Type 2 Diabetes Mellitus
Dong-A ST Co., Ltd.

Unknown

Observational Study to Evaluate the Efficacy and Safety of Suganon Tab. or Sugamet XR Tab.

Diabetes Mellitus, Type 2

Korea, Republic of
GlaxoSmithKline

Completed

A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Korea, Republic of, Malaysia, Philippines, Thailand, Russian Federation, Mexico
Asan Medical Center
REDNVIA Co., Ltd.

Not yet recruiting

Randomized, Open-label Trial of Inhibitory Effect of Evogliptin on Progression of CAVD

CAVD

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic Dysfunction

Liver Dysfunction

Korea, Republic of
Chengdu Easton Biopharmaceuticals Co,Ltd

Recruiting

A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Evaluate the Clinical Efficacy and Safety of Yogliptin Tablets

Type 2 Diabetes

China
IKFE Institute for Clinical Research and Development

Completed

Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With Insulin (PIOswitch)

Type 2 Diabetes Mellitus | Insulin Resistance

Germany
Laboratorios Silanes S.A. de C.V.

Completed

Effect of Oral Combination Therapy in a Single Dosage Form in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Mexico
Laboratorios Silanes S.A. de C.V.

Recruiting

Oral Combination of Glimepiride/Vildagliptin/Metformin in Patients With T2D and Dual Treatment Failure

Type 2 Diabetes

Mexico
GlaxoSmithKline

Terminated

An Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes Patients

Diabetes Mellitus, Type 2

China
Sanofi

Completed

Evaluation of Fixed Dose Combination of Glimepiride and Metformin in Chinese Type 2 Diabetes Patients Inadequately Controlled With Metformin

Type 2 Diabetes Mellitus

China
Dong-A ST Co., Ltd.

Completed

A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin

Type 2 Diabetes Mellitus

Korea, Republic of
Sanofi

Completed

Efficacy and Safety of Glimepiride as Oral Anti-Diabetic (OAD) Initiation Mono-therapy in Chinese Type 2 Diabetes Mellitus (T2DM) (GREAT)

Diabetes Mellitus, Type 2

China
Dong-A ST Co., Ltd.

Completed

A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01(Evogliptin/Metformin XR 2.5/500 mg x 2 Tablets) Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg in Healthy Male Volunteers

Type 2 Diabetes Mellitus

Korea, Republic of
Kaiser Permanente
Patient-Centered Outcomes Research Institute; Henry Ford Health System; HealthPartners... and other collaborators

Recruiting

Comparison of Type 2 Diabetes Pharmacotherapy Regimens (ON TARGET DM)

Cardiovascular Diseases | Type 2 Diabetes Mellitus

United States
LG Life Sciences

Unknown

Phase III Trial to Evaluate the Efficacy and Safety of Gemigliptin 50mg qd Added to Ongoing Glimepiride as Fix-dose Combination in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Korea, Republic of
Kyunghee University Medical Center
Sanofi; Korea University Guro Hospital; Hanyang University; The Catholic University... and other collaborators

Completed

Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin Therapy (KIIT)

Type 2 Diabetes Mellitus | Pancreatic Beta Cell Function | Glucotoxicity

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01 Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg, and to Evaluate the Effect of Food on the Pharmacokinetics of DA-1229_01 in Healthy Male Volunteers

Type 2 Diabetes Mellitus

Korea, Republic of
Handok Inc.

Completed

Teneligliptin-Glimepiride DDI Study

Diabetes Mellitus
LG Life Sciences

Completed

Pharmacokinetic Drug Interaction Study Between Gemigliptin and Glimepiride in Healthy Male Subjects

Healthy

Korea, Republic of
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Glimepiride 1mg Tablets Under Fed Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Glimepiride 1mg Tablets Under Fasting Conditions

Healthy

United States
Sanofi

Completed

Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride

Diabetes Mellitus

France
Sanofi

Completed

Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients (RECOMMEND)

Diabetes Mellitus, Type 2

Algeria, Colombia, Egypt, Guatemala, India, Iran, Islamic Republic of, Lebanon, Mexico, Russian Federation, South Africa, Tunisia, Turkey, Ukraine, United Arab Emirates
Sanofi

Completed

Glimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
Handok Inc.

Completed

Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination Therapy

Type 2 Diabetes Mellitus

Korea, Republic of
Merck Sharp & Dohme LLC

Completed

Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus (MK-0000-253)

Type 2 Diabetes Mellitus
Kurume University

Unknown

Pioglitazone Decreases Visceral Fat Metabolism

To Evaluate the Effect of Pioglitazone on Glucose Metabolism of Fat Tissue by Using FDG-PET/CT Imaging

Japan
Takeda

Completed

TAK-875 Glimepiride Drug-Interaction Study

Pharmacokinetics

United States
Sanofi

Completed

Comparative Study of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of Glimepiride

Type 2 Diabetes Mellitus

Japan
Sanofi

Completed

Initiation and Titration of Amaryl (AMIT KZ)

Diabetes Mellitus, Type 2

Kazakhstan
Chong Kun Dang Pharmaceutical

Completed

The Pharmacokinetic Interaction Between CKD-501 and Sulfonylurea (CKD-501 DDI)

Healthy Male Volunteer

Korea, Republic of
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Dr.Reddys Laboratories Limited, Glimepiride 1 mg Tablets in Healthy Subjects Under Fed Condition

Healthy

Canada
Dong-A ST Co., Ltd.

Completed

Efficacy and Safety of Evogliptin When Added to Ongoing Metformin and Dapagliflozin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Type2 Diabetes

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases

Type2 Diabetes | Non-Alcoholic Fatty Liver Disease

Korea, Republic of
Sanofi

Completed

ADIponectin and Asymmetric Dimethylarginine (ADMA) Level in Type-2 Diabetes Patients After 12 Weeks of Treatment With GlimepiRide And Metformin Fixed Dose Combination (DIAGRAM)

Diabetes Mellitus, Type 2

Indonesia
Takeda

Completed

Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.

Diabetes Mellitus

Germany
Laboratorios Silanes S.A. de C.V.

Completed

Endothelial Disfunction Treatment With Glimepiride/Metformin Combination (Glimetal) in Type 2 Diabetes Patients

Diabetes Mellitus | Endothelial Dysfunction

Mexico
Brain-Gut Research Group
Maastricht University Medical Center; Aalborg University

Unknown

Effects of Blueberries on Symptoms and Underlying Mechanisms of Functional Gastrointestinal Disorders

Functional Gastrointestinal Disorders

Switzerland
Laboratorios Silanes S.A. de C.V.
Instituto Mexicano del Seguro Social

Completed

BIOAVAILABILITY OF Glimepiride/Extended Release Metformin (GLI/METXR): High Fat Diet Study (GLMT13)

Healthy

Mexico
Sanofi

Completed

Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil)

Diabetes Mellitus

Brazil

3

Subscribe